Navigating the cutting edge: Hot topics in interstitial lung disease
Sponsored by Boehringer Ingelheim
| 1000-1800 | Postgraduate Workshop: Navigating the cutting edge: Hot topics in interstitial lung disease | |
| Session Title: Navigating ILD diagnosis Chair: Ingrid Cox | ||
| 1000-1005 | Introduction | |
| 1005-1025 | Navigating the grey zone between ILAs and early ILD: Highlights of the clinical statement | |
| 1025-1045 | IIP classification guidelines – a review of the 2025 guidelines | |
| 1045-1105 | Genetic insights into ILD diagnosis and care | |
| 1105-1125 | Leveraging AI-driven imaging analysis for early ILD detection, characterization and prognostication | |
| 1125-1130 | General discussion and wrap up | |
| 1130-1200 | Morning Tea | |
| Chair: Nathan Mortimer | ||
| 1200-1220 | Beyond the clinic: Empowering ILD patients through connected care: Remote monitoring, self-monitoring and virtual care | |
| 1220-1240 | Treatment of IPF/PPF – an update | |
| 1240-1300 | Addressing comorbidities in the management of ILDs | |
| 1300-1320 | Pharmacological management of CTD-ILD: Role of immunosuppressants | |
| 1320-1330 | General questions | |
| 1330-1430 | Lunch | |
| Session Title: MDM Chair: Vidya Navaratnam | ||
| 1420-1435 | Case management of the complex ILD patient | |
| 1435-1550 | Live multidisciplinary team case simulation: Panel discussion and interactive session | |
| 1350-1600 | General discussion and wrap up | |
| 1600-1630 | Afternoon Tea | |
| Session Title: Looking to the future Chair: Ella Smalley | ||
| 1630-1650 | Beyond the sum of its parts: A new framework for understanding fibrotic lung disease | |
| 1650-1710 | Environmental risk factors for ILDs: Current insights and future directions | |
| 1710-1730 | Emerging frontiers in ILD diagnostics | |
| 1730-1750 | Next-gen ILD therapies | |
| 1750-1755 | General discussion and wrap up | |
| 1755-1800 | Closing |
Key Dates
ABSTRACT SUBMISSION
CLOSED
EARLYBIRD REGISTRATION
OPEN
EARLYBIRD DEADLINE
19 January 2026